About NeuroMetrix
NeuroMetrix is a company based in Woburn (United States) founded in 1996 by Shai N Gozani was acquired by ElectroCore in December 2024. NeuroMetrix has raised $14.58 million across 6 funding rounds from investors including MIT, ElectroCore and 180 Degree Capital. The company has 26 employees as of December 31, 2023. NeuroMetrix offers products and services including Quell Fibromyalgia and DPNCheck. NeuroMetrix operates in a competitive market with competitors including Remedee Labs, Sky Medical Technology, Electromedical Technologies, Galvani Bioelectronics and Sublimed, among others.
- Headquarter Woburn, United States
- Employees 26 as on 31 Dec, 2023
- Founders Shai N Gozani
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neurometrix, Inc.
-
Annual Revenue
$3.03 M (USD)-49as on Dec 31, 2024
-
Net Profit
-$6.53 M (USD)-48as on Dec 31, 2023
-
EBITDA
-$8.78 M (USD)-23as on Dec 31, 2024
-
Total Equity Funding
$14.58 M (USD)
in 6 rounds
-
Latest Funding Round
$21 M (USD), Post-IPO
Jun 03, 2016
-
Investors
MIT
& 9 more
-
Employee Count
26
as on Dec 31, 2023
-
Acquired by
ElectroCore
(Dec 17, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NeuroMetrix
NeuroMetrix offers a comprehensive portfolio of products and services, including Quell Fibromyalgia and DPNCheck.
Wearable neuromodulator to reduce fibromyalgia symptoms.
Rapid test for detecting peripheral neuropathies in patients.
People of NeuroMetrix
Unlock access to complete
Unlock access to complete
Funding Insights of NeuroMetrix
NeuroMetrix has successfully raised a total of $14.58M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $21 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NeuroMetrix
NeuroMetrix has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include MIT, ElectroCore and 180 Degree Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Locked | Locked | Locked | |
|
Investments are made in life sciences firms across all stages.
|
Locked | Locked | Locked | |
|
Private equity firm focused on company buyouts
|
Locked | Locked | Locked |
Investor details for NeuroMetrix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NeuroMetrix
Investment portfolio details for NeuroMetrix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NeuroMetrix
Detailed financials for NeuroMetrix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurometrix Comparisons
Peer comparison for NeuroMetrix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NeuroMetrix
NeuroMetrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Remedee Labs, Sky Medical Technology, Electromedical Technologies, Galvani Bioelectronics and Sublimed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Endorphin stimulation therapy for pain management is developed.
|
|
| Locked | Locked | Locked |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| Locked | Locked | Locked |
An electrotherapy device that helps reduce and eliminate chronic or acute pain
|
|
| Locked | Locked | Locked |
Implantable neuromodulation devices for chronic disease treatment are developed.
|
|
| Locked | Locked | Locked |
Developer of pain management devices
|
Detailed competitors of NeuroMetrix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurometrix
Complete news archive for NeuroMetrix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroMetrix
NeuroMetrix was founded in 1996 and raised its 1st funding round 7 years after it was founded.
NeuroMetrix is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Shai N Gozani is the current CEO of NeuroMetrix. They have also founded this company.
NeuroMetrix is a funded company, having raised a total of $14.58M across 6 funding rounds to date.
As of Dec 31, 2023, the latest employee count at NeuroMetrix is 26.
Annual revenue of NeuroMetrix is $3.03M as on Dec 31, 2024.
NeuroMetrix develops wearable medical technology and point-of-care tests for chronic pain, nerve diseases, and sleep disorders. Products include Quell (wearable for pain relief), Sensus (neurostimulation device for diabetic neuropathy associated pain), DPN Check (test for diabetic neuropathy) and the Advance NCS platform for the performance of nerve conduction studies. Went public in 2004. Its Quell device stimulates the sensory nerves in the leg, with the signal traveling up to the brain. This signal in the brain releases endogenous opioids into the spine which provide relief from chronic pain.
NeuroMetrix's top competitors include Remedee Labs, Sky Medical Technology and Electromedical Technologies.
NeuroMetrix offers Quell Fibromyalgia and DPNCheck.
NeuroMetrix has 10 investors. Key investors include MIT, ElectroCore, 180 Degree Capital, Deerfield, and Delphi Ventures.